Evidence map›Paper›PMID 7768624›Full record

ArticleInfection and immunity1995

Reversal of lipopolysaccharide-analog-induced antibody suppression by anti-transforming growth factor beta and indomethacin.

M J Odean, A G Johnson, M Mohrman, A Hasegawa

Abstract read
In one paragraph

Article in Infection and immunity, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M J OdeanDepartment of Medical Microbiology and Immunology, University of Minnesota, Duluth 55812, USA.
A G Johnson
M Mohrman
A Hasegawa

Funding

ADJUVANT ACTION OF A NON-TOXIC MONOPHOSPHORYL LIPID AU01AI025810 · NIAID · UNIVERSITY OF MINNESOTA DULUTH · PI JOHNSON, ARTHUR GILBERT · 1987 to 1988
–
NIAID NIH HHS U01 AI 25810
6 · The paper itself

Abstract

Monophosphoryl lipid A and a synthetic, nontoxic monosaccharide analog of lipid A, termed GLA 60, both strongly suppressed antibody production when administered 1 to 2 days prior to antigen. Evidence is presented that this suppression was mediated by two cytokines, prostaglandin E and transforming growth factor beta, because it was reversed by multiple injections of the cyclooxygenase inhibitor indomethacin and by in vitro addition of antibody to transforming growth factor beta.

Indexed as

AnimalsAntibody FormationDinoprostoneFemaleIndomethacinLipid AMaleMiceMice, Inbred BALB CSheepTransforming Growth Factor betaDinoprostoneGLA 60IndomethacinLipid Amonophosphoryl lipid ATransforming Growth Factor beta

Identifiers

PMID7768624
PMCPMC173314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.